Literature DB >> 7470074

Organic-acid transport in resealed haemoglobin-containing human erythrocyte 'ghosts'.

A R Hubbard, U Sprandel, R A Chalmers.   

Abstract

The transport of organic acids across the membrane of resealed haemoglobin-containing erythrocyte 'ghosts' prepared by a dialysis technique has been studied. The present work forms part of studies directed towards the use of erythrocyte cellular carriers in enzyme-replacement therapy of inherited metabolic diseases. Oxalic acid, glycollic acid and glyoxylic acid were taken as representative of aliphatic acids of low molecular mass and benzoic and cinnamic acids as representative of unsubstituted aromatic acids. These selected acids are important in the diseases with which the present work is concerned. Comparison of influx and efflux transport characteristics showed that erythrocyte 'ghosts' retain transport properties closely similar to those of normal erythrocytes. Rapid transport was observed with all organic acids studied and there was a linear relationship between initial amount of influx and external concentration of aliphatic acid. Saturation of the transport system was not observed up to 1 mM external concentration, and the presence of plasma in the external medium had no effect on transport characteristics. Transport in intact erythrocytes and prepared erythrocyte 'ghosts' from patients with hyperoxaluria was also studied.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7470074      PMCID: PMC1162143          DOI: 10.1042/bj1900653

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Molecular features of organic anion permeablity in ox red blood cell.

Authors:  L Aubert; R Motais
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

2.  The role of carbonic anhydrase inhibitors on anion permeability into ox red blood cells.

Authors:  J L Cousin; R Motais
Journal:  J Physiol       Date:  1976-03       Impact factor: 5.182

3.  Enzyme loading of erythrocytes.

Authors:  G M Ihler; R H Glew; F W Schnure
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

4.  High-yield entrapment of proteins into erythrocytes.

Authors:  G L Dale; D G Villacorte; E Beutler
Journal:  Biochem Med       Date:  1977-10

Review 5.  Oxalic acid metabolism in man: a review.

Authors:  A Hodgkinson; P M Zarembski
Journal:  Calcif Tissue Res       Date:  1968-10-21

6.  Treatment of primary hyperoxaluria.

Authors:  C E Dent; T C Stamp
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

7.  In vitro studies on resealed erythrocyte ghosts as protein carriers.

Authors:  U Sprandel; A R Hubbard; R A Chalmers
Journal:  Res Exp Med (Berl)       Date:  1979-07-20

8.  Enzymatic degradation of uric acid by uricase-loaded human erythrocytes.

Authors:  G Ihler; A Lantzy; J Purpura; R H Glew
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  Enzyme loading of electrically homogeneous human red blood cell ghosts prepared by dielelctric breakdown.

Authors:  U Zimmermann; F Riemann; G Pilwat
Journal:  Biochim Biophys Acta       Date:  1976-06-17

Review 10.  Oxaluria.

Authors:  R W Watts
Journal:  J R Coll Physicians Lond       Date:  1973-01
View more
  4 in total

1.  Laboratory-scale finned-rotor impeller for dialysis.

Authors:  M A el-Kalay; A E Nasser
Journal:  Med Biol Eng Comput       Date:  1989-09       Impact factor: 2.602

2.  Towards enzyme therapy using carrier erythrocytes.

Authors:  U Sprandel; A R Hubbard; R A Chalmers
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

3.  Studies of lactate dehydrogenase in the purified state and in intact erythrocytes.

Authors:  R J Simpson; K M Brindle; F F Brown; I D Campbell; D L Foxall
Journal:  Biochem J       Date:  1982-03-15       Impact factor: 3.857

4.  Stability of erythrocyte ghosts: a gamma-ray perturbed angular correlation study.

Authors:  C A Kruse; G W Tin; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.